A company called BioViva is getting calls from athletes, trainers, and coaches looking to use one of its gene therapies, says New Scientist. The company claims the experimental therapy blocks the breakdown of muscle tissue, which would be useful for athletes looking for more efficient ways to build muscle or keep their muscles from breaking down. And even though there's no clear evidence yet that the therapy does what it's supposed to do, the athletes keep calling.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.